Arena Pharmaceuticals Profit Margin

Arena Pharmaceuticals posts a profit margin of -1141542.59% as of December 2021. That compares with -126875.86% in the prior-year period — down 799.7% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Arena Pharmaceuticals's profit margin was -126875.86%. The latest reading is -1141542.59% — a 799.7% year-over-year decrease (period ending December 2021). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. Arena Pharmaceuticals's -1141542.59% is lower that level. That is roughly 5966984.6% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Arena Pharmaceuticals's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -1141542.59% as of December 2021; use YoY and peer views to separate noise from signal.

Context for ARNA's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; Arena Pharmaceuticals's other metric pages and overview cover the third.